Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4775722 | 0.94 | SIGMAR1 (0.47) | SIGMAR1KIF11CHRM2CHRM3CHRM4 | |
| SCHEMBL28187244 | 0.92 | SIGMAR1 (0.46) | SIGMAR1CHRM2CHRM3CHRM4CHRM5 | |
| SCHEMBL9782412 | 0.92 | SIGMAR1 (0.46) | SIGMAR1CHRM2CHRM3CHRM4CHRM5 | |
| SCHEMBL6471777 | 0.92 | SIGMAR1 (0.46) | SIGMAR1CHRM2CHRM3CHRM4CHRM5 | |
| SCHEMBL28187243 | 0.92 | SIGMAR1 (0.46) | SIGMAR1CHRM2CHRM3CHRM4CHRM5 | |
| Benzene SCHEMBL27446323 | 0.88 | SIGMAR1 (0.44) | SIGMAR1CHRM2CHRM3CHRM4CHRM5 | |
| SCHEMBL7459315 | 0.86 | SMN1; SMN2 (0.44) | SIGMAR1ESR1ESR2CHRM2CHRM3 | |
| SCHEMBL5159643 | 0.83 | SIGMAR1 (0.62) | SIGMAR1CHRM2CHRM3CHRM4CHRM5 | |
| SCHEMBL62287 | 0.83 | CYP1A2 (0.48) | SIGMAR1KIF11ESR1ESR2CHRM2 | |
| Hydrochloric Acid SCHEMBL10512222 | 0.81 | CHRM4 (0.62) | SIGMAR1CHRM2CHRM3CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2809634-A1 | METHODS AND COMPOSITIONS FOR STYRENE INHIBITION VIA IN SITU GENERATION OF QUINONE METHIDES | General Electric Company (US) | 2014-12-10 | — | — | EP | claimed |
| US-8901362-B2 | Methods and compositions for styrene inhibition via in situ generation of quinone methides | GENERAL ELECTRIC COMPANY (US) | 2014-12-02 | — | — | US | claimed |
| WO-2013116611-A1 | METHODS AND COMPOSITIONS FOR STYRENE INHIBITION VIA IN SITU GENERATION OF QUINONE METHIDES | GENERAL ELECTRIC COMPANY (US) | 2013-08-08 | — | — | WO | claimed |
| US-20130204053-A1 | METHODS AND COMPOSITIONS FOR STYRENE INHIBITION VIA IN SITU GENERATION OF QUINONE METHIDES | GENERAL ELECTRIC COMPANY (US) | 2013-08-08 | — | — | US | claimed |
| US-5262552-A | Optically active compounds and intermediates thereof, and process for manufacturing same | ASAHI DENKA KOGYO K.K. (JP) | 1993-11-16 | — | — | US | claimed |
| US-20240376256-A1 | ORGANIC BINDER, COMPOSITION FOR PRODUCING INORGANIC MATERIAL MOLDED ARTICLE, GREEN BODY, DEGREASED BODY, INORGANIC MATERIAL MOLDED ARTICLE, AND METHOD OF PRODUCING INORGANIC MATERIAL MOLDED ARTICLE | KUREHA CORPORATION (JP) | 2024-11-14 | — | — | US | disclosed |
| CN-117529377-A | Organic binder, composition for producing inorganic material molded body, green body, degreased body, inorganic material molded body, and method for producing inorganic material molded body | 株式会社吴羽 | 2024-02-06 | — | — | CN | disclosed |
| CN-116694539-B | Lactobacillus plantarum J26 as direct vat set starter, and preparation method and application thereof | 东北农业大学 | 2023-11-17 | — | — | CN | disclosed |
| WO-2023286509-A1 | ORGANIC BINDER, COMPOSITION FOR PRODUCING INORGANIC MATERIAL MOLDED ARTICLE, GREEN BODY, DELIPIDATION BODY, INORGANIC MATERIAL MOLDED ARTICLE, AND INORGANIC MATERIAL MOLDED ARTICLE PRODUCTION METHOD | 株式会社クレハ | 2023-01-19 | — | — | WO | disclosed |
| CN-108473724-A | Nitrile rubber composition, crosslinkable nitrile rubber composition, and rubber crosslinked product | 日本瑞翁株式会社 | 2018-08-31 | — | — | CN | disclosed |
| EP-2809634-B1 | METHODS AND COMPOSITIONS FOR STYRENE INHIBITION VIA IN SITU GENERATION OF QUINONE METHIDES | GEN ELECTRIC (US) | 2018-01-31 | — | — | EP | disclosed |
| US-20150118480-A1 | LOW DENSITY EPOXY COMPOSITION WITH LOW WATER UPTAKE | 3M INNOVATIVE PROPERTIES COMPANY | 2015-04-30 | — | — | US | disclosed |
| CN-1938387-B | Surface-modified metal oxides, methods for production and use thereof in cosmetic preparations | BASF AG | 2010-09-29 | — | — | CN | disclosed |
| CN-101160188-A | Method for producing ultra-fine metal flakes | NANODYNAMICS INC (US) | 2008-04-09 | — | — | CN | disclosed |
| CN-1938387-A | Surface-modified metal oxides, methods for production and use thereof in cosmetic preparations | BASF AG (DE) | 2007-03-28 | — | — | CN | disclosed |
| US-5504219-A | Optically active compounds and intermediates thereof, and process for manufacturing same | ASAHI DENKA KOGYO K.K. (JP) | 1996-04-02 | — | — | US | disclosed |
| US-5352845-A | Process for manufacture of optically active saturated compounds | ASAHI DENKA KOGYO K.K. (JP) | 1994-10-04 | — | — | US | disclosed |
| US-5262552-A | Optically active compounds and intermediates thereof, and process for manufacturing same | ASAHI DENKA KOGYO K.K. (JP) | 1993-11-16 | — | — | US | disclosed |
| EP-0160258-B1 | (6,11-DIHYDRO-11-OXODIBENZ(BM,E)OXEPINYL)PENTANOLS, A PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-09-27 | — | — | EP | disclosed |
| US-3956402-A | MICROBIOCIDES | CIBA-GEIGY CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130204053-A1 | METHODS AND COMPOSITIONS FOR STYRENE INHIBITION VIA IN SITU GENERATION OF QUINONE METHIDES | ADH1A, ADH1C, ADH5 | SIGMAR1 4510/4885KIF11 762/4885ESR1 3825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.